RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

237 hedge funds and large institutions have $4.79B invested in Ultragenyx Pharmaceutical in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 89 increasing their positions, 74 reducing their positions, and 31 closing their positions.

Holders
237
Holders Change
+5
Holders Change %
+2.16%
% of All Funds
3.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
89
Reduced
74
Closed
31
Calls
$7.01M
Puts
$15.1M
Net Calls
-$8.14M
Net Calls Change
-$1.01M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$245M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$863M
3
State Street
3
State Street
Massachusetts
$142M
4
ACA
4
Avoro Capital Advisors
New York
$16.7M
5
O
5
OrbiMed
New York
$16.5M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$243M
2
Invesco
2
Invesco
Georgia
$4.26M
3
Capital Research Global Investors
3
Capital Research Global Investors
California
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$95.5M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$23.1M
Name Market Value Shares Shares
Change 		Shares
Change %
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$863M 11,884,786 +359,697 +3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$433M 5,963,374 +42,806 +0.7%
Federated Hermes
3
Federated Hermes
Pennsylvania
$290M 3,987,728 +858 +0%
BlackRock
4
BlackRock
New York
$250M 3,440,671 -43,981 -1%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$245M 3,370,245 +492,842 +17%
Capital International Investors
6
Capital International Investors
California
$243M 3,345,026 -2,024,748 -38%
ClearBridge Investments
7
ClearBridge Investments
New York
$208M 2,863,921 +85,062 +3%
Capital World Investors
8
Capital World Investors
California
$201M 2,765,793 -1,051 -0%
Alkeon Capital Management
9
Alkeon Capital Management
New York
$172M 2,368,130 +60,000 +3%
State Street
10
State Street
Massachusetts
$142M 1,948,684 +269,843 +16%
AllianceBernstein
11
AllianceBernstein
Tennessee
$99.7M 1,373,429 +65,273 +5%
RI
12
RTW Investments
New York
$99.7M 1,373,284 – –
Citadel Advisors
13
Citadel Advisors
Florida
$95.5M 1,315,032 -128,415 -9%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$91.2M 1,255,524 -35,855 -3%
RSCM
15
Rock Springs Capital Management
Maryland
$74.7M 1,028,109 +144,188 +16%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$65.6M 902,900 +25,944 +3%
APM
17
Avidity Partners Management
Texas
$63.1M 869,000 +169,000 +24%
Goldman Sachs
18
Goldman Sachs
New York
$55.7M 767,241 +41,563 +6%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$54.8M 755,032 -94,511 -11%
First Trust Advisors
20
First Trust Advisors
Illinois
$52.6M 723,758 -18,883 -3%
Adage Capital Partners
21
Adage Capital Partners
Massachusetts
$50.8M 700,000 – –
Norges Bank
22
Norges Bank
Norway
$48.1M 662,676 +41,100 +7%
Charles Schwab
23
Charles Schwab
California
$39.3M 540,744 +14,561 +3%
SCM
24
Suvretta Capital Management
New York
$38.1M 525,100 +39,858 +8%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$35.2M 484,338 -62,253 -11%
1
2 3 4 5